Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Kanwar, Yashpal S ^a   Ota, Kosuke ^a   Yang, Qiwei ^a   Wada, Jun ^a   Kashihara, Naoki ^a   Tian, Yufeng ^a   Wallner, Elisabeth I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Embryonic development; Matrix metalloproteinase 2; Membrane type matrix metalloproteinase 1

Indexed keywords

COLLAGENASE; GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0033370837     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.277.6.f934     Document Type: Article

References (87)

1. Adamson, E. D. Growth factors and their receptors in development. Dev. Genet. 14: 159-164, 1993.
2. Alexander, C. M., E. J. Hansell, O. Behrendtsen, M. L. Flannery, N. S. Kishnani, S. P. Hawkes, and Z. Werb. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122: 1723-1736, 1996.
3. Azzam, H. S., G. Arand, M. E. Lippman, and E. W. Thompson. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst. 85: 1758-1764, 1993.
4. Bernfield, M., S. Banerjee, J. E. Koda, and A. C. Rapraeger. Remodeling of the basement membrane: morphogenesis and maturation. Ciba Found. Symp. 108: 179-196, 1984.
5. Birkedal-Hansen, H., W. G. I. Moore, M. K. Bodden, L. J. Windsor, B. Birkedal-Hansen, A. de Carlo, and J. A. Engler. Matrix metalloproteinases. Crit. Rev. Oral Biol. Med. 4: 197-250, 1993.
6. Bode, W., F. X. Gomis-Ruth, R. Huber, R. Zwilling, and W. Stocker. Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases. Nature 358: 164-167, 1992.
7. Brenner, C. A., R. R. Adler, D. A. Rappolee, R. A. Pedersen, and Z. Werb. Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev. 3: 848-859, 1989.
8. Brooks, P. C., S. Stromblad, L. C. Sanders, T. L. von Schalscha, R. T. Aimes, W. G. Stetler-Stevenson, J. P. Quigley, and D. A. Cheresh. Localization of matrix metalloproteinase MMP-2 to surface of invasive cells by interaction with integrin αvβ3. Cell 85: 683-693, 1996.
9. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50: 6184-6191, 1990.
10. Brown, P. D., D. E. Kleiner, E. J. Unsworth, and W. G. Stetler-Stevenson. Cellular activation of 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int. 43: 163-170, 1993.
11. Cao, J., H. Sato, T. Takino, and M. Seiki. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J. Biol. Chem. 270: 801-805, 1995.
12. Cazenave, C., C. A. Stein, N. Loreau, N. T. Thuong, L. M. Neckers, C. Subsinghe, C. Helene, J. S. Cohen, and J. J. Toulme. Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotide. Nucleic Acids Res. 17: 4255-4273, 1989.
13. Chirgwin, J. M., A. E. Przybla, R. J. MacDonald, and W. J. Rutter. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
14. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
15. Clapp, W. L., and D. R. Abrahamson. Gross anatomy of the kidney. In: Renal Pathology, edited by C. C. Tisher and B. M. Brenner. Philadelphia, PA: Lippincott, 1994, p. 3-59.
16. Corcoran, M. L., R. E. Hewitt, D. E. Kleiner, and W. G. Stetler-Stevenson. MMP-2: expression, activation and inhibition. Enzyme Protein 49: 7-19, 1996.
17. Cunha, G. R. Role of mesenchymal-epithelial interactions in normal and abnormal development of mammary gland and prostate. Cancer Suppl. 74: 1030-1044, 1994.
18. DeClerck, Y. A., N. Perez, H. Shimada, T. C. Boone, K. E. Langley, and S. M. Taylor. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52: 701-708, 1992.
19. Ekblom, P. Renal development. In: The Kidney, edited by D. W. Seidin and G. Giebisch, New York: Raven, 1992, p. 475-501.
20. Fukuda, Y., Y. Masuda, J.-I. Kishi, Y. Hashimoto, T. Hayakawa, H. Nogawa, and Y. Nakanishi. The role of collagens in cleft formation of mouse embryonic submandibular gland during initial branching. Development 103: 259-267, 1988.
21. Gilles, C., M. Polette, J. Piette, C. Munaut, E. W. Thompson, P. Birembaut, and J.-M. Foidart. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer 65: 209-213, 1996.
22. Gilliland, G., S. Perrin, K. Blanchard, and H. F. Bunn. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87: 2725-2729, 1990.
23. Grobstein, C., and J. Cohen. Collagenase: effect on the morphogenesis of embryonic salivary epithelium in vitro. Science 150: 626-628, 1965.
24. Hayakawa, T., J.-I. Kishi, and Y. Nakanishi. Salivary gland morphogenesis: possible involvement of collagenase. Matrix Suppl. 1: 344-351, 1992.
25. Heussen, C., and E. B. Dowdle. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing SDS and copolymerized substrates. Anal. Biochem. 102: 196-202, 1980.
26. Hewlett, A. R., and M. J. Bissell. The influence of tissue micro-environment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol. 2: 79-89, 1993.
27. Imai, K., E. Ohuchi, T. Aoki, H. Nomura, Y. Fujii, H. Sato, M. Seiki, and Y. Okada. Membrane-type matrix metalloproteinase-1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase-2. Cancer Res. 56: 2707-2710, 1996.
28. Kanwar, Y. S., Z. Z. Liu, A. Kumar, J. Wada, and F. A. Car one. Cloning of mouse c-ros renal cDNA, its role in development and relationship to ECM glycoproteins. Kidney Int. 48: 1646-1659, 1995.
29. Kanwar, Y. S., Z. Z. Liu, A. Kumar, M. I. Usman, J. Wada, and E. I. Wallner. D-Glucose-induced dysmorphogenesis of embryonic kidney. J. Clin. Invest. 98: 2478-2488, 1996.
30. Kanwar, Y. S., F. A. Carone, A. Kumar, J. Wada, K. Ota, and E. I. Wallner. Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development. Kidney Int. 52: 589-606, 1997.
31. Kinoh, H., H. Sato, Y. Tsunezuka, T. Takino, A. Kawashima, Y. Okada, and M. Seiki. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell Sci. 109: 953-959, 1996.
32. Kinoshita, T., H. Sato, T. Takino, M., Itoh, T. Akizawa, and M. Seiki. Processing of a precursor of 72-Kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res. 56: 2535-2538, 1996.
33. Kleiner, D. E., and W. G. Stetler-Stevenson. Structural biochemistry and activation of matrix metalloproteinases. Curr. Opin. Cell Biol. 5: 891-897, 1993.
34. Kleiner, D. E., and W. G. Stetler-Stevenson. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218: 325-329, 1994.
35. Kleinman, H. K., and H. W. Schnaper. Basement membrane matrices in tissue development. Am. J. Respir. Cell Mol. Biol. 8: 238-239, 1993.
36. Lallier, T., and M. Bronner-Fraser. Inhibition of neural crest attachment by integrin antisense oligonucleotides. Science 259: 692-695, 1993.
37. Lelongt, B., H. Makino, T. M. Dalecki, and Y. S. Kanwar. Role of proteoglycans in renal development. Dev. Biol. 128: 256-276, 1988.
38. Lelongt, B., G. Trugman, G. Murphy, and P. M. Ronco. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J. Cell Biol. 136: 1363-1373, 1997.
39. Levy, A. T., V. Cioce, M. E. Sobel, S. Garbisa, W. F. Grigioni, L. A. Liotta, and W. G. Stetler-Stevenson. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res. 51: 439-444, 1991.
40. Liu, Z. Z., J. Wada, A. Kumar, F. A. Carone, M. Takahasi, and Y. S. Kanwar. Comparative role of phosphotyrosine kinase domains of c-ros and c-ret proto-oncogenes in metanephric development with respect to growth factors and matrix morphogens. Dev. Biol. 178: 133-148, 1996.
41. Llano, E., A. M. Pendas, V. Knauper, T. Sorsa, T. Salo, E. Salido, G. Murphy, J. P. Simmer, J. D. Bartlett, and C. Lopez-Otin. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101-15108, 1997.
42. MacDougall, J. R., and L. M. Matrisian. Contributions of tumor and stromal matrix metallo-proteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14: 351-362, 1995.
43. Massova, I., L. P. Kotra, R. Fridman, and S. Mobashery. Matrix metalloproteinases: structure, evolution, and diversification. FASEB J. 12: 1075-1095, 1998.
44. Matrisian, L. M. The matrix-degrading metalloproteinases. Bioessays 14: 455-463, 1992.
45. Matrisian, L. M., and B. L. M. Hogan. Growth factor regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Top. Dev. Biol. 24: 219-259, 1990.
46. Mauviel, A. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53: 288-295, 1993.
47. Monteagudo, C., M. J. Merino, J. San-Juan, L. A. Liotta, and W. G. Stetler-Stevenson. Immuno-histochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am. J. Pathol. 136: 585-592, 1990.
48. 1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88: 603-613, 1997.
49. Nagase, H. Cell surface activation of progelatinase (proMMP-2) and cell migration. Cell Res. 8: 179-186, 1998.
50. Nagase, H., K. Suzuki, T. Morodomi, J. J. Enghild, and G. Salvesen. Activation mechanisms of precursor of matrix metalloproteinases 1, 2 and 3. Matrix Suppl. 1: 237-244, 1992.
51. Nakanishi, Y., F. Sugiura, J. Kishi, and T. Hayakawa. Collagenase inhibitor stimulates cleft formation during early morphogenesis of mice salivary gland. Dev. Biol. 113: 201-206, 1986.
52. Ota, K., W. G. Stetler-Stevenson, Q. Yang, A. Kumar, J. Wada, N. Kashihara, E. I. Wallner, and Y. S. Kanwar. Cloning of murine membrane type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Kidney Int. 54: 131-142, 1998.
53. Pei, D., and S. J. Weiss. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244-247, 1995.
54. Pei, D., and S. J. Weiss. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271: 9135-9140, 1996.
55. Poulsom, R., M. Pignatelli, W. G. Stetler-Stevenson L. A. Liotta, P. A. Wright, R. E. Jeffery, J. M. Longcroft, L. Rogers, and G. W. H. Stamp. Stromal expression of 72 kDa type IV collagenases (MMP-2) and TIMP mRNAs in colorectal neoplasia. Am. J. Pathol. 141: 389-396, 1992.
56. Puente, X. S., A. M. Pendas, E. Liano, G. Velasco, and C. Lopez-Otin. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56: 944-949, 1996.
57. Pyke, C., E. Ralfkiaer, K. Tryggvason, and K. Dano. Messenger RNA for 2 type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol. 142: 359-365, 1993.
58. Rankin, C. A., K. Suzuki, Y. Itoh, D. M. Ziemer, J. J. Grantham, J. P. Calvet, and H. Nagase. Matrix metalloproteinases and TIMPs in cultured C57BL/6J-cpk kidney tubules. Kidney Int. 50: 835-844, 1996.
59. Reponen, P., C. Sahlberg, P. Hugtala, T. Hurskainen, I. Thesleff, and K. Tryggvason. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J. Biol. Chem. 267: 7856-7862, 1992.
60. Sakurai, H., and S. K. Nigam. Transforming growth factor-β selectively inhibits branching morphogenesis but not tubulogenesis. Am. J. Physiol. 273 (Renal Physiol. 42): F139-F146, 1997.
61. Sakurai, H., and S. K. Nigam. In vitro branching tubulogenesis: implications for developmental and cystic disorders, nephron number, renal repair, and nephron engineering. Kidney Int. 54: 14-26, 1998.
62. Sakurai, H., T. Tsukamoto, C. A. Kjelberg, L. G. Cantley, and S. K. Nigam. EGF receptor ligands are a large fraction of in vitro branching morphogens secretor by embryonic kidney. Am. J. Physiol. 273 (Renal Physiol. 42): F463-F472, 1997.
63. Sanger, F., S. Nicklen, and A. R. Coulson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463-5467, 1977.
64. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. A matrix metalloproteinase expressed on surface of invasive tumor cells. Nature 370: 61-65, 1994.
65. Sato, H., T. Kinoshita, T. Takino, K. Nakayama, and M. Seiki. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393: 101-104, 1996.
66. Saxen, L. Organogenesis of the Kidney. New York: Cambridge University Press, 1987.
67. Shimizu, S., K. Malik, H. Sejima, J. Kishi, T. Hayakawa, and O. Koiwai. Cloning and sequencing of cDNA encoding a mouse tissue inhibitor of metalloproteinase-2. Gene 114: 291-292, 1992.
68. Stetler-Stevenson, W. G., H. C. Krutzsch, M. P. Wacher, I. M. K. Margulies, and L. A. Liotta. Activation of human type IV collagenase proenzyme. J. Biol. Chem. 264: 1353-1356, 1989.
69. Stetler-Stevenson, W. G., H. C. Krutzsch, and L. A. Liotta. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264: 17374-17378, 1989.
70. Stetler-Stevenson, W. G., P. D. Brown, M. Onisto, A. T. Levy, and L. A. Liotta. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265: 13933-13938, 1990.
71. Stetler-Stevenson, W. G. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol. 148: 1345-1350, 1996.
72. Strongin, A. Y., I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant, and G. I. Goldberg. Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270: 5331-5338, 1995.
73. Sympson, C. J., R. S. Talhouk, C. M. Alexander, J. R. Chin, S. M. Clift, M. J. Bissell, and Z. Werb. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125: 681-693, 1994.
74. Takino, T., H. Sato, A. Shinagawa, and M. Seiki. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem. 270: 23013-23020, 1995.
75. Takino, T., H. Sato, E. Yamamoto, and M. Seiki. Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. Gene 155: 293-298, 1995.
76. Tanney, D. C., L. Feng, A. S. Pollock, and D. H. Lovett. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Dev. Dyn. 213: 121-129, 1998.
77. Thomasset, N., A. Lochter, C. J. Sympson, L. R. Lund, D. R. Williams, O. Behrendtsen, Z. Werb, and M. J. Bissell. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am. J. Pathol. 153: 457-467, 1998.
78. Tokunaga, K., H. Taniguchi, K. Yoda, M. Shimizu, and S. Sakiyama. Nucleotide sequence of a cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res. 14: 2829-2832. 1986.
79. Vassali, J.-D., and M. S. Pepper. Membrane proteases in focus. Nature 370: 14-15, 1994.
80. v-related matrix receptors in metanephric development. J. Cell Biol. 132: 1161-1176, 1996.
81. Wallner, E. I., Q. Yang, D. R. Peterson, J. Wada, and Y. S. Kanwar. Relevance of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis. Am. J. Physiol. 275 (Renal Physiol. 44): F467-F477, 1998.
82. Warburton, D., M. Lee, M. A. Berberich, and M. A. Bernfield. Molecular embryology and study of lung development. Am. J. Respir. Cell Mol. Biol. 9: 5-9, 1993.
83. Ward, R. V., S. J. Atkinson, P. M. Slocombe, A. J. Docherty, J. J. Reynolds, and G. Murphy. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta 1079: 242-246, 1991.
84. Werb, Z., C. M. Alexander, and R. R. Adler. Expression and function of matrix metallo-proteinases in development. Matrix Suppl. 1: 337-343, 1992.
85. Wessells, N. K., and J. H. Cohen. Effect of collagenase on developing epithelia in vitro: lung, ureteric bud and pancreas. Dev. Biol. 18: 294-309, 1968.
86. Will, H., and B. Hinzmann. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231: 602-608, 1995.
87. Witty, J. P., J. H. Wright, and L. M. Matrisian. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell 6: 1287-1303, 1995.